← back to search

Ying Peng

Memorial Hospital of South Bend · US
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Neuroinflammation and Neurodegeneration Mechanisms, Circular RNAs in diseases, and Cancer-related molecular mechanisms research.
h-index
33
citations
6,733
works
104
NIH funding
primary concept
email

Recent publications

CB2R activation ameliorates late adolescent chronic alcohol exposure-induced anxiety-like behaviors during withdrawal by preventing morphological changes and suppressing NLRP3 inflammasome activation in prefrontal cortex microglia in mice
Brain Behavior and Immunity 2023cited by 81position: lastdoi
NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1G93A mutation and exerts neuroprotection in amyotrophic lateral sclerosis
Neurobiology of Disease 2023cited by 40position: lastdoi
MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1<sup>G93A</sup> Motor Neuron of Amyotrophic Lateral Sclerosis
Oxidative Medicine and Cellular Longevity 2022cited by 55position: lastdoi
Repetitive transcranial magnetic stimulation combined with cognitive behavioral therapy treatment in alcohol-dependent patients: A randomized, double-blind sham-controlled multicenter clinical trial
Frontiers in Psychiatry 2022cited by 11position: middledoi
Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity
Molecular Immunology 2020cited by 80position: lastdoi
An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme
Oncogene 2019cited by 93position: lastdoi
Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury
Journal of Neuroinflammation 2018cited by 287position: lastdoi
EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment
Journal of Neuroinflammation 2017cited by 87position: lastdoi
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
Journal of Translational Medicine 2013cited by 170position: lastdoi
miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma
Carcinogenesis 2013cited by 95position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jingrui Pan · Sun Yat-sen University5 papers (2018–2023)Xiangpen Li · Sun Yat-sen University4 papers (2017–2023)Hongxuan Wang · Jiangxi University of Traditional Chinese Medicine4 papers (2019–2023)Jialing Peng · Henan University3 papers (2019–2022)Lei He · Shandong University3 papers (2019–2023)Qingyu Shen · Sun Yat-sen University3 papers (2018–2023)Zhe Gong · Sun Yat-sen University2 papers (2018–2020)Shuwei Qiu · Anshan Normal University2 papers (2013–2017)Xiaoming Rong · Sun Yat-sen University1 papers (2023–2023)Jingjing Mo · Tobacco Research Institute1 papers (2022–2022)Jiande Li · Xinjiang Medical University1 papers (2023–2023)Xiongming Rong · Sun Yat-sen University1 papers (2019–2019)Yatao Yin · Ocean University of China1 papers (2017–2017)Ming‐Liang He · China National Nuclear Corporation1 papers (2013–2013)Xiao-Ni Zhang · Sun Yat-sen University1 papers (2023–2023)Yun Xu · The First Affiliated Hospital, Sun Yat-sen University1 papers (2017–2017)Biying Yang · Hunan University of Traditional Chinese Medicine1 papers (2023–2023)Huanan Luo · Southern Medical University1 papers (2013–2013)Yuanpei Zhang · Chinese Academy of Agricultural Sciences1 papers (2019–2019)Lei He · Sichuan University1 papers (2023–2023)